Open AccessAB052. P-20. Phase 2, open-label study of second-line M7824 treatment in patients with locally advanced or metastatic biliary tract cancer
Author(s) -
Mitesh J. Borad,
Milind Javle,
Junji Furuse,
ChihHung Hsu,
Markus Moehler,
DoYoun Oh,
Joon Oh Park,
Lin Shen,
Juan W. Valle,
Meng Li,
Christoph Helwig,
John Bridgewater
Publication year - 2019
Publication title -
hepatobiliary surgery and nutrition
Language(s) - English
Resource type - Journals
eISSN - 2304-389X
pISSN - 2304-3881
DOI - 10.21037/hbsn.2019.ab052
Subject(s) - medicine , biliary tract cancer , biliary tract , oncology , second line , gastroenterology , cancer , first line , gemcitabine